Zobrazeno 1 - 10
of 90
pro vyhledávání: '"R Ravi Shankar"'
Publikováno v:
U.Porto Journal of Engineering, Vol 8, Iss 6, Pp 90-101 (2022)
Saturation flow rate is the prime important parameter for the design of capacity of signal-controlled intersections. The width of the approach is one of the most important factors for the evaluation of saturation flow. But, in countries like India, d
Externí odkaz:
https://doaj.org/article/89a47d96a9c94a69b7be1744d8825573
Autor:
Juan José Gagliardino, Rosario Arechavaleta, Freddy Goldberg Eliaschewitz, Kristy Iglay, Kimberly Brodovicz, Claudio D. Gonzalez, Shengsheng Yu, R. Ravi Shankar, Olaf Heisel, Paul Keown, Kaan Tunceli
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 15, Iss , Pp 76-80 (2019)
Objective: To assess oral antihyperglycemic agents (OAHA) and/or statin treatment initiation in patients with type 2 diabetes (T2D) and time from diagnosis to both types of treatment initiation and intensification. Research design and methods: We rev
Externí odkaz:
https://doaj.org/article/dad7ad8d72054b25addf29d7f52d8d75
Publikováno v:
Traffic Injury Prevention. 24:331-337
Publikováno v:
Archives of Transport, Vol 40, Iss 4, Pp 7-14 (2016)
Roundabouts are replacing conventional unsignalized intersections in many parts of the world (Polus and Shmueli, 1997). Capacity estimation is necessary for designing a new roundabout, to analyze and improve the existing roundabout facilities. There
Externí odkaz:
https://doaj.org/article/fadb9a34fc5046d4859dead5b920e191
Autor:
Sudha S. Shankar, MD, R. Ravi Shankar, MD, Radha A. Railkar, PhD, Chan R. Beals, MD, PhD, Helmut O. Steinberg, MD, David E. Kelley, MD
Publikováno v:
Current Therapeutic Research, Vol 77, Iss C, Pp 83-89 (2015)
Background: Insulin resistance heightens the risk for type 2 diabetes mellitus and cardiovascular disease. Amelioration of insulin resistance may reduce this risk. The thiazolidinedone class of insulin sensitizers improves insulin action in individua
Externí odkaz:
https://doaj.org/article/237e5f55548b4bbf9db98612d8419417
Publikováno v:
Innovative Infrastructure Solutions. 7
Publikováno v:
Transportation Research Procedia. 48:698-706
Understanding pedestrian-vehicular interaction and individual’s responsive behaviour under mixed traffic flow condition is a complex task. Individual’s perception and risk taking to cross the road varies with pedestrian characteristics (age, gend
Autor:
R Ravi Shankar, Suneri Shah, Hee-Koung Joeng, Geraldine Mendizabal, Julia R DiBello, Yanfen Guan, Barbara J Stegmann, Eberhard Nieschlag, Hermann M Behre, Ronald S Swerdloff, Michelle C Fox, Keith D Kaufman
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(7)
Context Adolescent males with hypogonadotropic hypogonadism (HH) have traditionally been treated with exogenous testosterone (T) or human chorionic gonadotropin (hCG) to produce virilization; however, those modalities do not result in growth of the t
Autor:
Yulia Samoilova, Gregory T. Golm, Keith D. Kaufman, Martina Zilli, Yilong Zhang, Chandan Saha, Naim Shehadeh, Samuel S. Engel, Ron S. Newfield, Carmen A. Rosario, Asma Deeb, Lynn W. Scherer, R. Ravi Shankar, Raymond L. H. Lam, Muhammad Yazid Jalaludin, Philip Zeitler, Raymundo Garcia
Publikováno v:
Pediatric diabetesREFERENCES. 23(2)
OBJECTIVE To assess the efficacy and safety of DPP-4 inhibition with sitagliptin in youth with type 2 diabetes (T2D). STUDY DESIGN This was a 54-week, double-blind, randomized, controlled clinical trial evaluating the safety and efficacy of DPP-4 inh
Autor:
Keith D. Kaufman, Asma Deeb, Gregory T. Golm, Philip Zeitler, Martina Zilli, Carmen A. Rosario, Ron S. Newfield, R. Ravi Shankar, Lynn W. Scherer, Raymundo Garcia, Muhammad Yazid Jalaludin, Yulia Samoilova, Samuel S. Engel, Raymond L. H. Lam, Naim Shehadeh, Chandan Saha, Yilong Zhang
Publikováno v:
Pediatric diabetesREFERENCES. 23(2)
Objective To assess the efficacy and safety of sitagliptin in youth with type 2 diabetes (T2D) inadequately controlled with metformin ± insulin. Study design Data were pooled from two 54-week, double-blind, randomized, placebo-controlled studies of